Analysis of the demand for reference standards used in quality evaluation of biologicals

Quality evaluation of biologicals entails some specific considerations and problems associated with inherent variability of biological systems. This has implications not only for biological and immunological test methods, but for physical and physico-chemical methods as well. Usage of reference standards (RSs) has an important role to play in the improvement of evaluation of biologicals’ quality. Absence of some industry RSs, which have the status of national RSs, makes it impossible to standardize corresponding products and to assess comparability of test results obtained by different manufacturers for similar (similarly named) products. The first step in the creation of the national system of RSs for medicines is the analysis of the demand for RSs used in quality evaluation of medicines, including biologicals. The analysis of the range of RSs demonstrated that existing industry RSs are not sufficient for performing quality evaluation of available biologicals. At present new industry RSs are being developed.

стандартные образцы, национальный календарь профилактических прививок, календарь профилактических прививок по эпидемическим показаниям, биологические лекарственные средства, reference standards, national calendar of preventive vaccinations, calendar of preventive vaccinations for epidemiological indications, biologicals, list of essential medicines for medical use for 2017

1. European Pharmacopoeia. 8th ed. EDQM, 2014. Available from: http://online.edqm.eu/entry.htm.

2. United States Pharmacopoeia. 39 ed. United States Pharmacopoeial Convention; 2016.

3. The International Pharmacopoeia (First and Second Supl.) 4th ed. 2011. Available from: http://apps.who.int/phint/en/p/about.

4. Merkulov VA, Sakanyan EI, Volkova RA, Klimov VI, Shemeryankina TB, Yashkir VA. Pharmacopeia standard samples and their practical application in the national drug standardization system. Pharm Chem J. 2016; 50(4): 258–61 (in Russian).

5. Merkulov VA, Sakanyan EI, Klimov VI, Shemeryankina TB, Yashkir VA, Barmin AV. Modern approaches to development of reference substances for evaluation of the quality of pharmaceuticals. Pharm Chem J. 2015; 49(11): 54–6 (in Russian).

6. Volkova RA, Fadeikina OV, Klimov VI, Sakanyan EI, Olefir YuV, Merkulov VA, et al. Topical issues related to reference standards in the sphere of circulation of biological products. BIOpreparations. Prevention, Diagnosis, Treatment 2016; 16(4): 229–36 (in Russian).

7. Bondarev VP, Borisevich IV, Volkova RA, Fadeykina OV. Industry reference standards certification for the control of medical immunobiological preparations. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2013; (2): 28–32 (in Russian).

8. Recommendations for the preparation, characterization and establishment of international and other biological reference standards (revised 2004). Annex 2. In: WHO Expert Committee on Biological Standardization: fifty-fifth report. WHO Technical Report Series 932. 2004: Geneva, Switzerland. P. 73–131.

9. Q6B Specifications: Test procedures and acceptance criteria for biotechnological/biological products guidance for industry. ICH; 1999.

10. Volkova RA, Fadeykina OV, Movsesyants AA, Borisevich IV. The experience of L. A. Tarasevich State Scientific Research Institute for Standardization and Control of Medical and Biological Products in the development and certification of certified reference materials of medical immunobiological products. Reference Materials 2011; (4): 17–21 (in Russian).

11. Resolution of the Government of the Russian Federation, November 2, 2009, ¹ 884. On approval of the Position of the State service of reference materials of composition and properties of substances and materials (in Russian).

12. Borisevich IV, Supotnitskiy MV. Farewell to Tarasevich State Control Institute. BIOpreparations. Prevention, Diagnosis, Treatment 2011; (3): 6–14 (in Russian).

13. Fadeykina OV, Volkova RA, Borisevich IV, Movsesyans AA, Bondarev VP. Assessment of the current state of certification and use of branch reference materials of medical immunobiological preparations. Sertified Materials 2013; (3): 58–61 (in Russian).

14. Abramtseva MV, Nemirovskaya TI, Ustinnikova OB, Fadeykina OV, Volkova RA, Movsesyants AA. The development and certification of the industrial reference standard for identification of meningococcal polysaccharide vaccine group A. Genotyping problems of microorganisms. BIOpreparations. Prevention, Diagnosis, Treatment 2016; 16(4): 260–3 (in Russian).

15. Yunasova TN, Fadeykina OV, Sidorenko ES, Sukhanova LL, Shitikova OYu, Sarkisyan ÊÀ, et al. Evaluation of branch reference standard of activity vaccine for rubella. BIOpreparations. Prevention, Diagnosis, Treatment 2015; (3): 49–53 (in Russian).

16. Fadeykina OV, Kasina IV, Alekseeva SA, Kovtun VP, Burdina EN, Ermolaeva TN, et al. Application of branch standard sample of bacterial suspension opacity for microbial cells total concentration determination in suspension of anthrax, plague and brucellosis bacteria. Uspekhi sovremennogo estestvoznaniya 2015; (1–8): 1287–90 (in Russian).

17. Kasina IV, Goryaev ÀÀ, Rashchepkin LI, Fadeykina OV, Nemirovskaya TI, Ustinnikova OB, et al. Certification and shelf-life extension of a new batch of the branch reference standard for live tularemic vaccine’s specific activity and immunogenicity. Biopreparation. Prevention, Diagnosis, Treatment 2015; (4): 32–8 (in Russian).

18. On the approval of the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemiological indications: the order of the Ministry of Health of the Russian Federation of March 21, 2014 N 125í. Available from: https://goo.gl/ A7MfuH (in Russian).

19. On the approval of the list of essential medicines for medical use for 2017: disposition. Government order of the Russian Federation from December 28, 2016 N 2885-ð (in Russian).

20. Mukhacheva AV, Perekrest VV, Movsesyants AA, Sarkisyan KA, Volkova RA, Fadeykina OV, et al. Results of re-certification of the industry reference standard for determination of potency, specificity and necrotic activity of the smallpox vaccine. BIOpreparations. Prevention, Diagnosis, Treatment 2013; (4): 34–40 (in Russian).

21. Mukhacheva AV, Perekrest VV, Movsesyants AA, Sarkisyan KA, Butyrsky AYu, Fadeykina OV, et al. Re-certification of the industry reference standard and its use in quality evaluation of smallpox vaccines. Epidemiology and vaccinal prevention 2016; 15(6): 70–9 (in Russian).

22. Barkhaleva OA, Sinyugina AA, Sarkisyan KA, Ladyzhenskaya IP, Vorobyeva MS, Fadeykina OV, et al. Certification of a new batch of the industry reference standard for determination of specific activity of the yellow fever vaccine. BIOpreparations. Prevention, Diagnosis, Treatment 2013; (4): 41–7 (in Russian).

23. Volkova RA. Quality control of medical immunobiological preparations of chemical and immunochemical methods. Dr Biol Sci [thesis]. Moscow; 2009 (in Russian).

24. Kornilova OG, Arefyeva IL, Konovalova ES, Volkova RA, Fadeykina OV, Kudasheva EY, Movsesyants AA. Certification and potential future use of the reference standard designed for the test system for determination of the fractional (antigenic) composition of human serum products by immunoelectrophoresis. BIOpreparations. Prevention, Diagnosis, Treatment 2017; 17(2): 116–21 (in Russian).

25. Krivykh MA, Kornilova OG, Bunyatyan ND, Paramonova EV, Kudasheva EYu, Novikova EV, et al. Certification of standard samples of human immunoglobulin for determination of anticomplementary activity. Pharm Chem J. 2016; 50(12): 61–4 (in Russian).

26. Yakovlev AK, Gayderova LA, Alpatova NA, Lobanova TN, Postnova EL, Yurchikova EI, et al. Studying of the standardization principles of pharmacological activity of recombinant erythropoietin preparations. Sertified Materials 2016; (1): 8–20 (in Russian).

27. Motuzova EV, Alpatova NA, Gayderova LA, Runova OB, Volkova RA, Mytsa ED, et al. Development and certification of an industrial reference standard for determination of filgrastim activity. Biopreparations. Prevention, Diagnosis, Treatment 2016; 16(3): 172–8 (in Russian).

28. Ustinnikova OB, Runova OB, Goloschapova EO, Korsun LV. Theoretical rationale for the choice of interferon alfa-2b substance to be certified as a reference standard for identification test by peptide mapping. BIOpreparations. Prevention, Diagnosis, Treatment 2016; 16(3): 161–6 (in Russian).